Pretoria, 22 July 2022 - SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, clinched a Management Award at last night's 24th National Science and Technology Forum (NSTF) Awards, that recognises outstanding contributions to science, engineering and technology (SET), and innovation. According to NSTF, Dr Semete-Makokotlela earned her accolade as...
21 July 2022 Johannesburg – The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA) delivered an informative Compliance Workshop at the National Institute of Communicable Diseases (NICD) on Thursday, 21 July 2022. Radiation Control Manager, Kgomotso Tlhapi, led the workshop during the first...
Embargo: Immediate release Pretoria, 20 July 2022 – The South African Health Products Regulatory Authority (SAHPRA) has noted the numerous media articles on the statement made by Minister Sisulu, having secured medicine for the late Jessie Duarte. To this effect, SAHPRA is looking into the reports...
19 July 2022 Johannesburg – The South African Health Products Regulatory Authority (SAHPRA) and the UK’s Department for International Trade (DIT) signed a Memorandum of Understanding (MOU) today, in Sandton. The key objective of the MOU is to demonstrate the countries’ intentions to collaborate in good faith,...
14 July 2022 Radiation Control has released their latest FAQs for: X-RaysInspectorateRadionuclides ...
28 June 2022 The South African Health Products Authority (SAHPRA) is pleased to announce the launch of an Over the Counter (OTC) Online Medicines’ Directory for South African consumers and healthcare professionals. The domain name is https://medsinfo.sahpra.org.za and the portal is available on the SAHPRA website. The...
28 June 2022 Pretoria – The South African Health Products Regulatory Authority (SAHPRA) initially signed a Memorandum of Understanding (MOU) with the South African National Accreditation System (SANAS) in 2017 and this will now be extended in 2022. This MOU will now also incorporate the following activities...
Embargo: Immediate release Pretoria, 24 June 2022 – The South African Health Products and Regulatory Authority (SAHPRA) registered the COVID-19 vaccine, Coronavac, on 14 June 2022, with conditions. The registration was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101 of...
Embargo: Immediate release Pretoria, 23 June 2022 – SAHPRA has registered a new “sweet-tasting” combination antiretroviral treatment for infants and young children with HIV. This treatment comes in granules that can be sprinkled on soft food or dissolved in milk or water. Furthermore, this treatment does...
23 June 2022 The South African Health Products Regulatory Authority (SAHPRA) has been making strides in the use of the Med Safety App that reports on the Adverse Events Following Immunisation (AEFIs) and this is being noticed within the continent. SAHPRA has been working in conjunction with...
